Search clinical trials for: Hypofractionation Radiotherapy

Total 5673 results

Jena University Hospital
University Hospital Schleswig-Holstein; Klinikum Stuttgart

Not yet recruiting

Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer (ultraHART)

Quality of Life | Prostate Cancer | Adaptive Radiotherapy

Germany
National Cancer Institute (NCI)

Not yet recruiting

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Glioma | Astrocytoma | Recurrent Glioblastoma

United States
Mayo Clinic

Recruiting

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Biochemically Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma | Recurrent Prostate Adenocarcinoma

United States
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection

Thymus Neoplasms

China
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Not yet recruiting

Retifanlimab With Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma

Recurrent Glioblastoma | Recurrent WHO Grade 4 Glioma

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma (PHOX)

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage I Esophageal Adenocarcinoma AJCC v8 | Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Clinical Stage II Gastroesophageal Junction Adenocarcinoma... and other conditions

United States
Samsung Medical Center

Recruiting

Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer

Endometrial Cancer

Korea, Republic of
Ottawa Hospital Research Institute
Knight Therapeutics (USA) Inc

Recruiting

Dose Escalation For INtraprostatic LEsions (DEFINE)

Prostatic Neoplasms

Canada
Chang Gung Memorial Hospital

Not yet recruiting

HF-SRT vs. HS-WBRT in Treating Patients With Brain Oligometastases

Brain Oligometastases

Taiwan
Assistance Publique - Hôpitaux de Paris

Recruiting

Impact of Hypofractionated Radiotherapy Strategy After Surgery of Skin Carcinomas in Older Patients (IMPACTE-01)

Skin Cancer, Non-Melanoma

France
CHU de Quebec-Universite Laval

Recruiting

Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost. (HYPO-5)

Prostate Cancer | Localized Prostate Carcinoma | Radiotherapy Side Effect | Radiotherapy | Brachytherapy | Hypofractionation

Canada
Latin American Cooperative Oncology Group

Recruiting

Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study (RADIANT)

Radiotherapy Side Effect

Brazil
University Hospital Inselspital, Berne
University of Bern; Debiopharm International SA; Werner und Hedy Berger-Janser...

Recruiting

Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical Prostatectomy (HypoFocal SRT)

Recurrent Prostate Cancer

Switzerland
The Netherlands Cancer Institute
Radboud University Medical Center; Universitaire Ziekenhuizen KU Leuven

Recruiting

Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer

Prostate Cancer

Netherlands
Erasmus Medical Center
Dutch Cancer Society

Recruiting

HRQOL in Prostate Cancer Patients Treated With Radiotherapy (PRORAD)

Prostate Cancer

Netherlands
Cancer Institute and Hospital, Chinese Academy...

Recruiting

A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN) (BIRKIN)

Breast Neoplasms

China
Barretos Cancer Hospital

Recruiting

Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction (PROMART)

Breast Cancer

Brazil
Ruijin Hospital

Recruiting

RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/Truebeam

Breast Cancer

China
Joris B.W. Elbers
Erasmus Medical Center; HollandPTC

Recruiting

HYpofractionated, Dose-redistributed RAdiotherapy With Protons and Photons in HNSCC (HYDRA)

Head and Neck Squamous Cell Carcinoma | Radiotherapy | Proton Therapy | Hypofractionation | Immune System Suppression

Netherlands
Erasmus Medical Center

Recruiting

A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer (UPRATE)

Prostate Cancer

Netherlands
Universitaire Ziekenhuizen KU Leuven

Recruiting

Observational Study on Extreme Hypofractionation for Localized Prostate Cancer (OBELIX PCa)

Prostate Cancer | Radiotherapy | SBRT

Belgium
University Health Network, Toronto

Recruiting

Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer (MOB-RT)

Prostate Cancer

Canada
The First Affiliated Hospital of Xiamen University

Recruiting

Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC

Colorectal Neoplasms

China
Seoul National University Bundang Hospital
Seoul National University Hospital

Not yet recruiting

Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients

Breast Cancer | Radiotherapy; Complications
University of Santo Tomas Hospital, Philippines
Philippine Council for Health Research & Development

Not yet recruiting

HYpofractionated Pelvic Radiotherapy for Advanced Cervical Cancers INeligible for ChemoTherapy (HYACINCT)

Locally Advanced Cervical Carcinoma
Sohag University

Recruiting

One Week Adjuvant Radiotherapy for Breast Cancer

Breast Carcinoma

Egypt
University of Utah
National Cancer Institute (NCI)

Recruiting

Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer (RT-PACE)

Cervical Carcinoma | Endometrial Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Study

Diffuse Midline Glioma, H3 K27M-Mutant

United States
Royal North Shore Hospital

Recruiting

Breast Fractionation Study - Standard Versus Investigational Fractionation Trial - Nodal Radiation

Breast Cancer | Post Mastectomy

Australia
Boston Scientific Corporation

Recruiting

Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy (SABRE)

Prostate Cancer

Australia, Spain, United States, United Kingdom, Germany, Ireland, France, Italy, Switzerland
M.D. Anderson Cancer Center

Recruiting

NBTXR3, Radiation Therapy, and Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Recurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell Carcinoma

United States
Chang Gung Memorial Hospital

Recruiting

A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT (HF-SRT)

Brain Metastases, Adult

Taiwan
University Medical Center Groningen
Dutch Cancer Society

Recruiting

PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy (PERYTON)

Prostate Cancer | Cancer Recurrence

Netherlands
McGill University Health Centre/Research Institute...

Recruiting

Pre-operative RadiothErapy for Soft Tissue SarcOmas (PRESTO)

Soft Tissue Sarcoma Adult

Canada
British Columbia Cancer Agency

Recruiting

5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) (PROMPT)

Oligometastatic Prostate Cancer

Canada
Mona Salem
Kasr El Aini Hospital

Recruiting

Weekly Single Fraction Hypofractionated Adjuvant Radiotherapy for Early Stage Breast Cancer

Breast Cancer | Radiotherapy Side Effect

Egypt
Postgraduate Institute of Medical Education and...

Recruiting

HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART). (HYPART)

Breast Cancer | Radiotherapy Side Effect | Hypofractionation

India
Alexandria University

Recruiting

Hypofractionation And Ultra-Hypofractionation In Adjuvant Radiotherapy For Breast Cancer

Breast Cancer

Egypt
Mary Feng, MD
AstraZeneca

Recruiting

Hypofractionated Radiotherapy Followed by Durvalumab With or Without Tremelimumab for Liver Cancer After Progression on PD-1 Inhibition

Advanced Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IVB Hepatocellular Carcinoma AJCC v8 | Stage IIIB Hepatocellular Carcinoma...

United States
University of Texas Southwestern Medical Center

Recruiting

HYPORT: A Phase I/II Study of Hypofractionated Post-operative Radiation Therapy for Head and Neck Cancer

Squamous Cell Carcinoma of Head and Neck

United States
National Cancer Institute (NCI)

Recruiting

Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients

Stage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Recurrent Lung Non-Small Cell Carcinoma

United States
Icahn School of Medicine at Mount Sinai

Recruiting

Hypofractionated Radiotherapy in Elderly Patients With Head & Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma (HNSCC)

United States
Emory University
National Cancer Institute (NCI)

Recruiting

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study (HiPPI)

Schwannoma | Grade III Meningioma | Intracranial Neoplasm | Nerve Sheath Neoplasm | Grade II Meningioma | Grade I Meningioma | Pituitary Gland Adenoma

United States
Ontario Clinical Oncology Group (OCOG)

Recruiting

Hypofractionated LocoRegional Radiotherapy in Breast Cancer (RHEAL)

Breast Neoplasms | Lymphedema | Radiotherapy

Canada
National Cancer Institute (NCI)

Recruiting

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to Radiation Therapy for Localized Pancreatic Cancer

Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Locally Advanced Pancreatic Adenocarcinoma | Locally Advanced Unresectable Pancreatic Adenocarcinoma | Unresectable Pancreatic Adenocarcinoma

United States
National Cancer Institute (NCI)

Recruiting

Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Cholangiocarcinoma | Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Gallbladder Carcinoma | Stage III Gallbladder Cancer AJCC v8 | Stage III Hilar Cholangiocarcinoma AJCC v8 | Stage IV Gallbladder Cancer AJCC v8 | Stage IV Hilar Cholangiocarcinoma AJCC v8 | Stage IV Intrahepatic Cholangiocarcinoma...

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer

Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8

United States
Asan Medical Center

Recruiting

Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy (SHARE)

Quality of Life | Prostate Cancer | Radiation Toxicity | Biochemical Recurrence | Survival | Radiation | Hypofractionation | Dose Escalation

Korea, Republic of
Danish Lung Cancer Group
Odense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Herlev Hospital and other collaborators

Recruiting

Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC

Radiotherapy Side Effect | Stage IV Non-small Cell Lung Cancer | Stage III Non-small-cell Lung Cancer

Denmark
The Second Hospital of Hebei Medical University

Recruiting

NSCLC Isotoxic Hypofractionated Radiotherapy (IHR)

Carcinoma, Non-Small-Cell Lung

China

Search clinical trials for: Hypofractionation Radiotherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations